Umeå universitets logga

umu.sePublikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
The myeloid cell biomarker EMR1 is ectopically expressed in colon cancer
Umeå universitet, Medicinska fakulteten, Institutionen för strålningsvetenskaper, Onkologi. Umeå universitet, Medicinska fakulteten, Institutionen för klinisk mikrobiologi, Immunologi/immunkemi. Department of Pathology, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt.
Umeå universitet, Medicinska fakulteten, Institutionen för klinisk mikrobiologi, Immunologi/immunkemi.
Institution of Clinical Sciences, Lund University, SE, Lund, Sweden.
Umeå universitet, Medicinska fakulteten, Institutionen för klinisk mikrobiologi, Immunologi/immunkemi.ORCID-id: 0000-0001-6182-4423
Visa övriga samt affilieringar
2021 (Engelska)Ingår i: Tumor Biology, ISSN 1010-4283, E-ISSN 1423-0380, Vol. 43, nr 1, s. 209-223Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

OBJECTIVE: The microenvironment of colon cancer (CC) is heterogeneous including cells of myeloid lineage affecting tumor growth and metastasis. Two functional subtypes of myeloid cells have been identified; one (M1) is tumor-inhibitory and the other one (M2) is tumor-promoting. Whether the three myeloid markers EMR1, CD206 and CD86 are expressed only in the infiltrating myeloid cells or also in the tumor cells was investigated.

METHODS: Expression of the myeloid markers was investigated in CC at the mRNA and protein levels in primary tumors and lymph nodes. mRNA expression was also determined in 5 CC cell lines. Protein expression was investigated by two-color immunofluorescence and consecutive-sections-immune-staining combined with morphometry using specific antibodies for the myeloid cell markers and the epithelial cell markers CEACAM5 and EpCAM.

RESULTS: EMR1 and CD86, but not CD206, mRNA levels were significantly higher in CC primary tumors compared to apparently normal colon tissue (P <  0.0001). EMR1 mRNA levels were significantly higher in both hematoxylin-eosin positive (H&E(+)) and H&E(-) lymph nodes of CC patients compared to control nodes (P = 0.03 and P = 0.01, respectively). EMR1 and CD206 mRNAs were expressed in 4/5 and 5/5 CC cell lines, respectively, while CD86 mRNA was not expressed. Immuno-morphometry revealed that about 20% of the tumor cells expressed EMR1 and CD206. Positive cells were tumor cells as revealed by anti-CEACAM5 and anti-EpCAM staining. The number of EMR1, CD206 and CD86 positive cells were significantly increased in CC primary tumors compared to normal colon tissue (P <  0.0001). However, CD206 was also expressed in normal colonocytes. Only EMR1 showed significantly increased numbers of positive tumor cells in H&E(+) nodes compared to H&E(-) nodes (P = 0.001). EMR1 expression in CC tumor cells correlated with CXCL17 expressing tumor cells.

CONCLUSION: EMR1, like the chemokine CXCL17, is ectopically expressed in colon cancer possibly in the same cancer cells.

Ort, förlag, år, upplaga, sidor
IOS Press, 2021. Vol. 43, nr 1, s. 209-223
Nyckelord [en]
CD206, CD86, chemokines, EMR1, epithelial cell markers
Nationell ämneskategori
Cancer och onkologi Cell- och molekylärbiologi
Identifikatorer
URN: urn:nbn:se:umu:diva-188165DOI: 10.3233/TUB-200082PubMedID: 34486997Scopus ID: 2-s2.0-85115819829OAI: oai:DiVA.org:umu-188165DiVA, id: diva2:1600968
Tillgänglig från: 2021-10-06 Skapad: 2021-10-06 Senast uppdaterad: 2021-10-06Bibliografiskt granskad

Open Access i DiVA

fulltext(4132 kB)327 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 4132 kBChecksumma SHA-512
51cbe478fa6f87e5529ec273d7320d735207178f9775bbe27769f6cab6f423cca14418ebef52c7ec2ecf5cf366c65c798351bbf95a69b24eda88f7cd23ee9b17
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltextPubMedScopus

Person

Ali, HaythamOhlsson, LinaHammarström, Marie-LouiseHammarström, StenSitohy, Basel

Sök vidare i DiVA

Av författaren/redaktören
Ali, HaythamOhlsson, LinaHammarström, Marie-LouiseHammarström, StenSitohy, Basel
Av organisationen
OnkologiImmunologi/immunkemi
I samma tidskrift
Tumor Biology
Cancer och onkologiCell- och molekylärbiologi

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 329 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 825 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf